We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

immunology

Illuminating the Future of Biological Research: mFluor Violet Conjugated Antibodies

Post-COVID Conditions or Long COVID and COVID Long-Haulers

Is Monkeypox Still A Threat?

The NLRP3 Inflammasome: Macrophage Activator & Pathology Driver

Hypoxia-Dependent CAR Stabilizing Construct in T cells Improves Solid Tumor Targeting and Efficacy

Tired T cells: Hypoxia Drives T cell Exhaustion in the Tumor Microenvironment

Synthetic Biotic Medicine as Immunotherapy Against Cancer: Evidence From Arginine-Producing Engineered Bacteria

Harnessing Natural Killer Cell Activity for Anti-Tumor Immunotherapy

Early T cell response is associated with mild COVID-19 and rapid SARS-CoV-2 clearance

New mass spectrometry technique presents new questions about MHC II expression regulation

Pages